Speeches by Beales.

“India is now rolling out generic Ozempic. What assessment have you made or do you have any general sense of what the availability of generics might mean for that QALY assessment and the £15.2 billion price tag and when that may be applicable?”

“Kieran, Pharmacy2U suggested in its evidence that your sector could provide these services for £300 a year, compared with £1,200 a year. What drives that price differential?”

“Is there a sense that you are underpricing—that you are seeking to present quite a low-cost option, perhaps cutting back some things? I an not saying necessarily that this is what you get if you go straight to your GP, but I think NHS England’s guidance talks about the need for five psychologist sessions. We certainly …”

“This is perhaps a question for you all. How do you monitor engagement and take-up in the additional services you provide? Are you confident that the videos that you are providing, the consultations, are being utilised by the patient? We have all done online HR mandatory modules, where we click very quickly to get throu…”

“So you just refer back to the NHS to deal with the issues?”

“Would that lead to additional services that you would provide and charge for or—”

“Can you do that in a light-touch model of prescribing, I guess that more sustained engagement and behavioural change, perhaps dealing with some underlying issues that are quite deep-seated and long term? People might have been battling with, as you say, different diet and exercise programmes, mental health issues or pe…”

“Human to human interaction?”

“The extra support you provide, is that all benchmarked into the price; there is no additional pricing? Are there additional options you offer to people with varying prices attached?”

“Is that one-to-one support or signposted?”

“How much is that?”

“Good morning. The NICE appraisal talked about the importance of wraparound care associated with the treatments, and the NHS England proposal talked about a number of different appointments that people required. Simon, I think you touched on the number of GP appointments. What does the wraparound care offer look like fo…”

“Could you give a sense of what that might mean for that £15.2 billion?”

“Is the nutritionist, etc, all included in the cost up front?”

“Kieran and Simon, is there any similarity in additional structured pricing options, depending on the level of support, or is it just one flat price?”

“I think Juniper also mentioned that people are twice as likely to achieve weight loss in the model, to your point, Claire. What evidence do you have about the long-term and sustained impacts of your approaches around weight loss? I guess this is one of the common questions about these interventions with GLP-1. Are you …”

“Is a blood test clinically indicated? Are they recommended as part of the normal treatment pathways?”

“Do you get a sense of when biosimilars may be available?”

“I will just pick up on that point about competitiveness and competitive advantage. Is it not the case that those much-visited cities—Paris, Rome, many cities in Spain and others throughout Europe—have measures such as this proposed levy, yet they have not seen decreases in tourism? How is that a competitive advantage p…”

“If any of those issues come back indicative of potential low risk or high risk or diagnosed conditions, what happens to the patient then?”